UCP2 and hepatocellular carcinoma: In the present study, using cellular models of HCC cell lines clinically treated with GEM, we investigated the involvement of UCP2 expression in rendering cellular resistance to GEM and the anti-tumoral effect of GEM treatment associated to UCP2 inhibition.